| Chugai Pharmaceutical (CHGCY) |
Japan |
$98.336B |
34.35 |
| Takeda Pharmaceutical (TAK) |
Japan |
$58.453B |
11.48 |
| Zoetis (ZTS) |
United States |
$55.369B |
19.57 |
| BeOne Medicines - (ONC) |
Switzerland |
$37.990B |
201.41 |
| Sandoz Group AG (SDZNY) |
Switzerland |
$37.704B |
0.00 |
| Daiichi Sankyo, - (DSNKY) |
Japan |
$35.538B |
17.70 |
| United Therapeutics (UTHR) |
United States |
$20.501B |
18.04 |
| Shionogi (SGIOY) |
Japan |
$19.413B |
15.01 |
| Merck (MKKGY) |
Germany |
$19.276B |
11.88 |
| IPSEN (IPSEY) |
France |
$14.799B |
0.00 |
| Ionis Pharmaceuticals (IONS) |
United States |
$13.246B |
0.00 |
| Neurocrine Biosciences (NBIX) |
United States |
$12.355B |
26.70 |
| Orion OYJ (ORINY) |
Finland |
$11.463B |
19.91 |
| Summit Therapeutics (SMMT) |
United States |
$11.282B |
0.00 |
| Madrigal Pharmaceuticals (MDGL) |
United States |
$10.760B |
0.00 |
| Eisai (ESAIY) |
|
$9.309B |
0.00 |
| Ono Pharmaceutical (OPHLF) |
Japan |
$7.562B |
18.09 |
| Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$4.828B |
0.00 |
| Stevanato Group S.p.A (STVN) |
Italy |
$4.724B |
26.44 |
| AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$4.599B |
21.84 |
| Crinetics Pharmaceuticals (CRNX) |
United States |
$4.504B |
0.00 |
| Indivior Pharmaceuticals (INDV) |
United States |
$4.221B |
17.22 |
| Corcept Therapeutics (CORT) |
United States |
$4.033B |
43.57 |
| NewAmsterdam Pharma (NAMS) |
Netherlands |
$3.953B |
0.00 |
| Centessa Pharmaceuticals (CNTA) |
United Kingdom |
$3.260B |
0.00 |
| Catalyst Pharmaceuticals (CPRX) |
United States |
$2.901B |
9.25 |
| Hypermarcas (HYPMY) |
Brazil |
$2.755B |
18.91 |
| Dyne Therapeutics (DYN) |
United States |
$2.285B |
0.00 |
| Avadel Pharmaceuticals (AVDL) |
Ireland |
$2.113B |
0.00 |
| Guardian Pharmacy Services (GRDN) |
United States |
$2.099B |
40.43 |
| Soleno Therapeutics (SLNO) |
United States |
$2.075B |
0.00 |
| Ocular Therapeutix (OCUL) |
United States |
$1.972B |
0.00 |
| Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$1.887B |
22.36 |
| Harrow (HROW) |
United States |
$1.745B |
107.09 |
| Ardelyx (ARDX) |
United States |
$1.703B |
0.00 |
| Enliven Therapeutics (ELVN) |
United States |
$1.612B |
0.00 |
| Definium Therapeutics (DFTX) |
United States |
$1.599B |
0.00 |
| Oruka Therapeutics (ORKA) |
United States |
$1.580B |
0.00 |
| Amylyx Pharmaceuticals (AMLX) |
United States |
$1.545B |
0.00 |
| Relay Therapeutics (RLAY) |
United States |
$1.527B |
0.00 |
| Nektar Therapeutics (NKTR) |
United States |
$1.444B |
0.00 |
| BioCryst Pharmaceuticals (BCRX) |
United States |
$1.433B |
85.00 |
| Collegium Pharmaceutical (COLL) |
United States |
$1.431B |
7.09 |
| Evotec AG (EVO) |
Germany |
$1.219B |
0.00 |
| Savara (SVRA) |
United States |
$1.186B |
0.00 |
| Xeris Biopharma Holdings (XERS) |
United States |
$1.147B |
0.00 |
| Theravance Biopharma (TBPH) |
United States |
$0.983B |
41.28 |
| Cronos Group (CRON) |
Canada |
$0.977B |
0.00 |
| Aktis Oncology (AKTS) |
United States |
$0.907B |
0.00 |
| ARS Pharmaceuticals (SPRY) |
United States |
$0.871B |
0.00 |
| Xencor (XNCR) |
United States |
$0.830B |
0.00 |
| Esperion Therapeutics (ESPR) |
United States |
$0.813B |
0.00 |
| KalVista Pharmaceuticals (KALV) |
United States |
$0.764B |
0.00 |
| Ironwood Pharmaceuticals (IRWD) |
United States |
$0.750B |
17.73 |
| Bioventus (BVS) |
United States |
$0.670B |
13.73 |
| Rigel Pharmaceuticals (RIGL) |
United States |
$0.621B |
5.55 |
| ProKidney (PROK) |
United States |
$0.596B |
0.00 |
| Lyell Immunopharma (LYEL) |
United States |
$0.539B |
0.00 |
| 4D Molecular Therapeutics (FDMT) |
United States |
$0.535B |
0.00 |
| Altimmune (ALT) |
United States |
$0.516B |
0.00 |
| Lexeo Therapeutics (LXEO) |
United States |
$0.480B |
0.00 |
| Siga Technologies (SIGA) |
United States |
$0.478B |
6.55 |
| Organogenesis (ORGO) |
United States |
$0.475B |
0.00 |
| Zevra Therapeutics (ZVRA) |
United States |
$0.473B |
0.00 |
| Nature's Sunshine Products (NATR) |
United States |
$0.464B |
27.60 |
| Aquestive Therapeutics (AQST) |
United States |
$0.458B |
0.00 |
| Elite Pharmaceuticals (ELTP) |
United States |
$0.454B |
0.00 |
| USANA Health Sciences (USNA) |
United States |
$0.383B |
10.69 |
| Aclaris Therapeutics (ACRS) |
United States |
$0.364B |
0.00 |
| Akebia Therapeutics (AKBA) |
United States |
$0.361B |
0.00 |
| Protara Therapeutics (TARA) |
United States |
$0.337B |
0.00 |
| Aldeyra Therapeutics (ALDX) |
United States |
$0.316B |
0.00 |
| Relmada Therapeutics (RLMD) |
United States |
$0.286B |
0.00 |
| Minerva Neurosciences (NERV) |
United States |
$0.272B |
0.00 |
| Avalo Therapeutics (AVTX) |
United States |
$0.267B |
0.00 |
| Larimar Therapeutics (LRMR) |
United States |
$0.266B |
0.00 |
| Enlivex Therapeutics (ENLV) |
Israel |
$0.261B |
0.00 |
| Journey Medical (DERM) |
United States |
$0.256B |
0.00 |
| OmniAb (OABI) |
United States |
$0.243B |
0.00 |
| Profound Medical (PROF) |
Canada |
$0.226B |
0.00 |
| Context Therapeutics (CNTX) |
United States |
$0.223B |
0.00 |
| MediWound (MDWD) |
Israel |
$0.220B |
0.00 |
| Achieve Life Sciences (ACHV) |
Canada |
$0.220B |
0.00 |
| Silence Therapeutics (SLN) |
United Kingdom |
$0.214B |
0.00 |
| Surrozen (SRZN) |
United States |
$0.213B |
0.00 |
| Heron Therapeutics (HRTX) |
United States |
$0.211B |
0.00 |
| Tonix Pharmaceuticals Holding (TNXP) |
United States |
$0.184B |
0.00 |
| Galectin Therapeutics (GALT) |
United States |
$0.181B |
0.00 |
| Innate Pharma SA (IPHYF) |
France |
$0.181B |
0.00 |
| AleAnna (ANNA) |
United States |
$0.171B |
0.00 |
| Karyopharm Therapeutics (KPTI) |
United States |
$0.164B |
0.00 |
| Century Therapeutics (IPSC) |
United States |
$0.153B |
0.00 |
| Prelude Therapeutics (PRLD) |
United States |
$0.141B |
0.00 |
| Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.137B |
0.00 |
| VAXART, INC (VXRT) |
United States |
$0.136B |
0.00 |
| Unicycive Therapeutics (UNCY) |
United States |
$0.131B |
0.00 |
| Inhibikase Therapeutics (IKT) |
United States |
$0.123B |
0.00 |
| Cardiol Therapeutics (CRDL) |
Canada |
$0.114B |
0.00 |
| Avita Medical (RCEL) |
United States |
$0.113B |
0.00 |
| Korro Bio (KRRO) |
United States |
$0.111B |
0.00 |
| Cassava Sciences (SAVA) |
United States |
$0.099B |
0.00 |
| Incannex Healthcare (IXHL) |
Australia |
$0.093B |
0.00 |
| Vivani Medical (VANI) |
United States |
$0.091B |
0.00 |
| Verrica Pharmaceuticals (VRCA) |
United States |
$0.089B |
0.00 |
| Pyxis Oncology (PYXS) |
United States |
$0.084B |
0.00 |
| Champions Oncology (CSBR) |
United States |
$0.083B |
35.00 |
| Assertio Holdings (ASRT) |
United States |
$0.078B |
0.00 |
| PolyPid (PYPD) |
Israel |
$0.073B |
0.00 |
| HST Global (HSTC) |
United States |
$0.069B |
0.00 |
| Gain Therapeutics (GANX) |
United States |
$0.067B |
0.00 |
| Rafael Holdings (RFL) |
United States |
$0.062B |
0.00 |
| PMV Pharmaceuticals (PMVP) |
United States |
$0.057B |
0.00 |
| BioNxt Solutions (BNXTF) |
Canada |
$0.057B |
0.00 |
| Cumberland Pharmaceuticals (CPIX) |
United States |
$0.057B |
47.38 |
| Fractyl Health (GUTS) |
United States |
$0.056B |
0.00 |
| Procaps Group, S.A (PROCF) |
Luxembourg |
$0.056B |
0.00 |
| Dominari Holdings (DOMH) |
United States |
$0.053B |
0.00 |
| NRx Pharmaceuticals (NRXP) |
United States |
$0.051B |
0.00 |
| Acrivon Therapeutics (ACRV) |
United States |
$0.050B |
0.00 |
| Nutriband (NTRB) |
United States |
$0.049B |
0.00 |
| Lipocine (LPCN) |
United States |
$0.048B |
0.00 |
| ElectroCore (ECOR) |
United States |
$0.045B |
0.00 |
| FibroGen (FGEN) |
United States |
$0.039B |
0.00 |
| Lite Strategy (LITS) |
United States |
$0.038B |
0.00 |
| Talphera (TLPH) |
United States |
$0.038B |
0.00 |
| Telomir Pharmaceuticals (TELO) |
United States |
$0.037B |
0.00 |
| Plus Therapeutics (PSTV) |
United States |
$0.036B |
0.00 |
| Mural Oncology (MURA) |
Ireland |
$0.035B |
0.00 |
| SCYNEXIS (SCYX) |
United States |
$0.033B |
0.00 |
| Reviva Pharmaceuticals Holdings (RVPH) |
United States |
$0.030B |
0.00 |
| TherapeuticsMD (TXMD) |
United States |
$0.028B |
0.00 |
| Wellgistics Health (WGRX) |
United States |
$0.025B |
0.00 |
| MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.024B |
0.00 |
| Natural Alternatives (NAII) |
United States |
$0.021B |
0.00 |
| Jupiter Neurosciences (JUNS) |
United States |
$0.020B |
0.00 |
| VYNE Therapeutics (VYNE) |
United States |
$0.019B |
0.00 |
| Scienture Holdings (SCNX) |
United States |
$0.017B |
0.00 |
| Citius Pharmaceuticals (CTXR) |
United States |
$0.016B |
0.00 |
| Klotho Neurosciences (KLTO) |
United States |
$0.016B |
0.00 |
| Iterum Therapeutics (ITRM) |
Ireland |
$0.016B |
0.00 |
| Traws Pharma (TRAW) |
United States |
$0.015B |
0.02 |
| Liminatus Pharma (LIMN) |
United States |
$0.015B |
0.00 |
| Vyome Holdings (HIND) |
United States |
$0.015B |
0.00 |
| Vivos Therapeutics (VVOS) |
United States |
$0.015B |
0.00 |
| Cosmos Health (COSM) |
United States |
$0.014B |
0.00 |
| Mannatech (MTEX) |
United States |
$0.014B |
0.00 |
| Phio Pharmaceuticals (PHIO) |
United States |
$0.013B |
0.00 |
| BioLineRx (BLRX) |
Israel |
$0.013B |
0.00 |
| Tempest Therapeutics (TPST) |
United States |
$0.011B |
0.00 |
| Inotiv (NOTV) |
United States |
$0.010B |
0.00 |
| Addex Therapeutics (ADXN) |
Switzerland |
$0.010B |
0.00 |
| CASI Pharmaceuticals (CASI) |
China |
$0.009B |
0.00 |
| TransCode Therapeutics (RNAZ) |
United States |
$0.009B |
0.00 |
| BioVie (BIVI) |
United States |
$0.008B |
0.00 |
| Curanex Pharmaceuticals Inc (CURX) |
United States |
$0.008B |
0.00 |
| Kiora Pharmaceuticals (KPRX) |
United States |
$0.008B |
0.00 |
| XTL Biopharmaceuticals (XTLB) |
Israel |
$0.008B |
0.00 |
| Ainos (AIMD) |
United States |
$0.008B |
0.00 |
| Quoin Pharmaceuticals (QNRX) |
United States |
$0.007B |
0.00 |
| Nuvilex (PMCB) |
United States |
$0.007B |
0.00 |
| Biomerica (BMRA) |
United States |
$0.007B |
0.00 |
| Mangoceuticals (MGRX) |
United States |
$0.006B |
0.00 |
| Alaunos Therapeutics (TCRT) |
United States |
$0.006B |
0.00 |
| Xenetic Biosciences (XBIO) |
United States |
$0.005B |
0.00 |
| Aptorum Group (APM) |
United Kingdom |
$0.005B |
0.00 |
| Heatwurx (PCSA) |
United States |
$0.005B |
0.00 |
| Redhill Biopharma (RDHL) |
Israel |
$0.005B |
0.00 |
| Salarius Pharmaceuticals (SLRX) |
United States |
$0.005B |
0.00 |
| Sonoma Pharmaceuticals (SNOA) |
United States |
$0.005B |
0.00 |
| 60 Degrees Pharmaceuticals (SXTP) |
United States |
$0.004B |
0.00 |
| Indaptus Therapeutics (INDP) |
United States |
$0.004B |
0.00 |
| Galmed Pharmaceuticals (GLMD) |
Israel |
$0.003B |
0.00 |
| XORTX Therapeutics (XRTX) |
Canada |
$0.003B |
0.00 |
| Ernexa Therapeutics (ERNA) |
United States |
$0.003B |
0.00 |
| InMed Pharmaceuticals (INM) |
Canada |
$0.003B |
0.00 |
| China SXT Pharmaceuticals (SXTC) |
China |
$0.003B |
0.00 |
| Lyra Therapeutics (LYRA) |
United States |
$0.002B |
0.00 |
| Jaguar Animal Health (JAGX) |
United States |
$0.002B |
0.00 |
| SciSparc (SPRC) |
Israel |
$0.002B |
0.00 |
| CDT Equity (CDT) |
United States |
$0.002B |
0.00 |
| Shuttle Pharmaceuticals Holdings (SHPH) |
United States |
$0.002B |
0.00 |
| Universe Pharmaceuticals INC (UPC) |
China |
$0.002B |
0.00 |
| Clearmind Medicine (CMND) |
Canada |
$0.002B |
0.00 |
| PainReform (PRFX) |
Israel |
$0.001B |
0.00 |
| Aditxt (ADTX) |
United States |
$0.001B |
0.00 |
| Emisphere Technologies (EMIS) |
United States |
$0.000B |
0.00 |
| Grifols, S.A (GRFS) |
Spain |
$0.000B |
0.00 |
| 4D Pharma (LBPS) |
United Kingdom |
$0.000B |
0.00 |
| Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |
| RVL Pharmaceuticals (RVLP) |
United States |
$0.000B |
0.00 |
